Počet záznamov: 1
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer
SYS 0161442 LBL 00000naa^^22^^^^^^^^450 005 20200114105452.8 100 $a 20191210d2019 m y0sloy0103 ba 101 0-
$a eng 102 $a SK 200 1-
$a Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer $f Ray-Coquard I., Minárik T. ... [et al.] 305 $a Int J. Cancer. 2019 Aug 5 463 -1
$1 001 sllk_un_cat*0161376 $1 011 $a 1336-8176 $1 200 1 $a Onkológia $v Roč. 14, č. 5 (2019), s. 372 $1 210 $a Bratislava $c SOLEN $d 2019 $1 215 $a s. 299-374 606 1-
$3 sllk_un_auth*d010051 $a nádory vaječníkov $x farmakoterapia $2 mesh 606 1-
$3 sllk_un_auth*d004359 $a farmakoterapia kombinovaná $2 mesh 606 1-
$3 sllk_un_auth*d011505 $a proteíntyrozínkinázy $x antagonisty a inhibítory $2 mesh 606 2-
$3 sllk_un_auth*d016190 $a karboplatina $2 mesh 606 2-
$3 sllk_un_auth*d017239 $a paklitaxel $2 mesh 606 2-
$3 sllk_un_auth*d017326 $a skúšanie klinické, fáza III, ako téma $2 mesh 606 2-
$3 sllk_un_auth*d016896 $a výsledok liečby $2 mesh 610 2-
$a nintedanib 610 2-
$a štúdia AGO-OVAR 12 701 -1
$3 sllk_un_auth*0050559 $a Ray-Coquard $b I. $4 100 701 -1
$3 sllk_un_auth*0004471 $a Minárik $b Tomáš $4 100 $p Národný onkologický ústav, Bratislava 711 02
$3 sllk_un_auth*0012742 $a Redakcia Onkológia $4 010 801 -0
$a SK $b BA006 $c 20191210 $g AACR2
Počet záznamov: 1